Prescribing Update Catherine Armstrong Lead Pharmacist - Pharmicus.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

Pharmacovigilance, the MHRA and Yellow Cards Aileen McKenna Senior Clinical Pharmacist.
Management of Stroke and Transient Ischaemic Attack Sam Thomson.
Prescribing Update CATHERINE ARMSTRONG – NOVEMBER 2014.
SUA
Stroke Mark Sudlow Consultant and Senior Lecturer
Nottingham West CCG Prescribing Team Beth Carney/ Dawn Gajree / David Sharpe September 2014.
Antibiotics Medicines Management Team October 2008.
Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.
North of Tyne anti-platelet guidelines: use in primary care Jane S Skinner Consultant Community Cardiologist.
CVD risk estimation and prevention: An overview of SIGN 97.
Prescribing Update CATHERINE ARMSTRONG – MAY 2014.
Cholesterol and Lipids TIPS Wokefield Park 15/5/2013.
ELJF-CLINICAL v3.04 Quick 6-step tutorial in under 5 minutes.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
DYSLIPIDEMIA IN ADULTS WITH DIABETES* 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada *Updated in Leiter.
FATS4 Linking cases to the guideline Jane S Skinner Consultant Community Cardiologist.
Clinical experience with ezetimibe/simvastatin in a Mediterranean population The SETTLE Study I. Migdalis a, A. Efthimiadis b, St. Pappas c, D. Alexopoulos.
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Paediatric Prescribing and Common Medications Diana Mowbray Paediatric Clinical Pharmacist Rotherham NHS Foundation Trust.
Asthma Management Fine Tuning  Maximum control with minimum medication  Start with mild asthma and work up the scale (BTS/SIGN 2004)
European guidelines on the management of stable coronary artery disease Key points & new position for Ivabradine and Trimetazidine ESC 2013 Montalescot.
School of Clinical Medicine School of Clinical Medicine UNIVERSITY OF CAMBRIDGE Headache Jane Smith, a 23 year old woman, presents to her GP complaining.
STATINS AGAIN. Atorvastatin Off patent Atorvastatin 40 = £36 PA Simvastatin 40 = £14 PA Atorvastatin 80 = £72 PA Simvastatin 80 = £24 PA.
Hypertension NICE CG127 August Hypertension is not a disease it is a risk factor for cardiovasuclar disease (CVD)-it is a modifiable risk factor.
What’s the point of Ezetimibe? MeReC dio/cdlipids/merec_extra_no47.html.
Medicines management update Catherine Butler Medicines Management Pharmacist.
Clopidogrel Audit Vikas Jasoria December What is it? Clopidogrel is a thienopyridine antiplatelet drug which reduces platelet aggregation by inhibiting.
Collaborative Atorvastatin Diabetes Study CARDS Dr Sachin Kadoo.
CV Update – Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet – 27/01/09 Dr Ameet Bakhai, FRCP – Cardiologist, Clinical Trials, Health.
Primary Prevention Nice Guidelines. Who to offer therapy to? Offer lipid-modification therapyto people aged 84 years and younger if their estimated 10-year.
Manufacturer: Amgen Inc FDA Approval Date: August 27, 2015
The Hyperlipidaemias What are they and how to treat Dr John O’Donnell Consultant Clinical Biochemist Borders General Hospital.
Lead Medicines Management Technician North Derbyshire and Hardwick CCG.
ELIGIBILITY: MRC/BHF Heart Protection Study Increased risk of CHD death due to prior disease: Myocardial infarction or other coronary heart disease; Occlusive.
Pharmacy Service role in supporting informal carers Inverclyde Pharmacy Change Plan Natalie O’Gorman.
East & South East England Specialist Pharmacy Services East of England, London, South Central & South East Coast NSAIDS – Efficacy and Safety Expert speaker.
Prescribing in cardiovascular disease By Jole Hannan Medicines Optimisation Pharmacist.
Prescribing for patients with COPD Evidence Update Emma Blanden- Pharmacist.
Safe Opioid Prescribing MedicinesDoseFrequencyRouteQuantity Morphine Sulphate MR 10mg tablets10mgBD OralSupply 28 tablets (Twenty eight tablets) Morphine.
Pain Ladder and Opiate Conversion Christopher Haigh Medicines Optimisation Pharmacist Bolton CCG.
NICE guidance Generalised Anxiety Disorder Alex Hill.
Medicines and CKD Nikki Lawton Medicines Optimisation Pharmacist NMCCG.
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
Clinical Knowledge Summaries CKS Analgesia – mild to moderate pain Prescribing analgesics for mild to moderate pain in adults and children. Educational.
Specials November Update
Jessica Case study.
Co-amoxiclav prescribing: York House Medical Practice
Prescription Clerk Training
eLJF-CLINICAL Quick 6-step tutorial in just 3 minutes
Methotrexate in Psoriasis Shared Care Guidelines
Antiplatelet therapy for STEMI
Introduction to Clinical Pharmacy
ELIGIBILITY: MRC/BHF Heart Protection Study
Intensive Statin Recommendations
Repeat fasting lipid profile to confirm in 1-2 weeks
Patients aged 85yrs and over
Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.
Diabetes Dr. J. Antony Gagnon, Pharm.D., CDE, CAE
RCHC’s Cardiovascular Health Initiative
West Essex Frailty Pathway: COPD
eLJF-CLINICAL Quick 6-step tutorial in just 3 minutes
Relapses or deteriorates
Goals & Guidelines A summary of international guidelines for CHD
Train-the-Trainer Cases
Train-the-Trainer Cases
Train-the-Trainer Cases
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Section 6: Update on lipid treatment guidelines
Presentation transcript:

Prescribing Update Catherine Armstrong Lead Pharmacist - Pharmicus

GMC – Good Practice in Prescribing & Managing Medicines and Devices Effective from Must explain and justify decisions / actions YOU are responsible for any script you sign Several MUSTs and SHOULDs Full guidance available:

GMC – Unlicensed Medicines GMC recommends that GPs can prescribe unlicensed or “off license” medicines but, if you decide to do so, you must: Be satisfied that an alternative, licensed medicine would not meet the patient's needs Be satisfied that there is a sufficient evidence base and/or experience of using the medicine to demonstrate its safety and efficacy Take responsibility for prescribing the medicine and for overseeing the patient's care, including monitoring and any follow up treatment Record the medicine prescribed and, where you are not following common practice, the reasons for choosing this medicine in the patient's notes. (Code 8B2V)

Which are specials? Drug Paracetamol 120mg/5ml Paracetamol 250mg/5ml Paracetamol 500mg/5ml Morphine 10mg/5ml Morphine 20mg/5ml Morphine 20mg/1ml Average cost £1.12 per 200ml £1.30 per 200ml £73.76 per 200ml £1.78 per 100ml £ per 420ml £4.98 per 30ml

Specials Is a liquid formulation needed? Is the drug readily available in a liquid form? Can another drug be substituted? e.g. fluoxetine liquid for sertraline tablets COST of licensed option is not a reason to avoid using

Controlled Drug Prescribing Form? Needs dose Not needed

Gastro-Intestinal Mucogel not Maalox Peptac not Gaviscon Advance – Can use Gaviscon Advance tablets for portability PPI – Omeprazole / Lansoprazole / Pantoprazole – Avoid Omeprazole 40mg – use 2x20mg – Consider C Diff risk

Domperidone Interaction Small increased risk of serious ventricular arrhythmia or sudden cardiac death Higher risk – Patients aged 60+ – Daily doses >30mg MHRA advice – Use lowest effective dose – Consider QT prolongation interacting meds

Metoclopramide Interaction August MHRA Drug Safety Update Contraindicated in <1 year old Restricted use/doses <18 years old Maximum of 30mg per day for 5 days in adults

MHRA Simvastatin Alert List of drugs contra-indicated with simvastatin List of drugs - maximum dose of simvastatin – Main action: amlodipine & diltiazem Primary Prevention – ↓ simvastatin 20mg Secondary prevention – depends on latest lipid profile Action at next review of patient

FATS6 - Secondary Prevention of CVD (symptomatic or prior occlusive vascular disease) Acute Coronary syndrome / Acute MI Initiate Atorvastatin 80mg All other conditions Simvastatin 40mg 1st-line (unless interactions) Repeat lipid profile 8 weekly and consider titration unless TC < 4mmol/l, LDL-C (fasting) < 2mmol, or non-HDL < 2.8mmol/l Titrate to Atorvastatin 40mg then 80mg

FATS6 - Type 1 and Type 2 diabetes Consider drug treatment in all Type 1 and 2 diabetics: with microalbuminuria/proteinuria (any age) over 40 years under 40 years if other CV risk factors present. Simvastatin 40mg 1st-line (unless interactions) Repeat lipid profile 8 weekly and consider titration unless TC < 4mmol/l, LDL-C (fasting) < 2mmol, or non-HDL < 2.8mmol/l Titrate to Atorvastatin 40mg then 80mg If Type 2 diabetes and triglycerides > 1.7 & < 10 mmol/l – lifestyle measures for 6 months then consider adding a fibrate (Fenofibrate 200mg daily, reduced doses in CKD)

FATS6 - Primary Prevention (no symptomatic or prior occlusive vascular disease) Treatment is based on risk and not cholesterol levels If 10 year CVD risk ≥ 20%, consider Simvastatin 40mg (reduce dose for drug interaction – more detail in full guidance)

FATS6 - Other points to note Consider familial hyperlipidaemia (FH) if TC > 7.5mmol/l, LDL cholesterol > 4.9 Suspected FH if triglycerides > 4.5mmol/l If triglycerides > 10mmol/l, seek specialist advice Simvastatin 80mg Prescribing of Simvastatin 80mg is no longer recommended due to risk of myopathy. Review patients taking Simvastatin 80mg their next routine appointment.

Dual Antiplatelet Therapy Aspirin 75mg daily STEMINSTEMIUNSTABLE ANGINA EITHERINVASIVE THERAPY TICAGRELOR 90MG BD FOR 12 MONTHS ORINVASIVE NOT SUITABLE PRASUGREL 5MG OR 10MG OD FOR 12 MONTHS CLOPIDOGREL 75MG OD FOR 12 MONTHS

Respiratory Beclometasone inhalers – BRAND Consider combinations 2 new COPD inhalers Consider quantities when reviewing

Pregabalin Avoid more than 1 capsule per dose QDS is not licensed, use maximum of TDS Each capsule/strength priced the same - £1.15 Most popular “street” drug abused

Paracetamol doses 120MG/5ML AGEDOSE 3-6M2.5ML 6-24M5ML 2-4Y7.5ML 4-6Y10ML ALL UP TO QDS 250MG/5ML AGEDOSE 6-8Y5ML 8-10Y7.5ML 10-12Y10ML ALL UP TO QDS Do NOT use in under 6yrs

Antibiotics “Preferred” antibiotics: AmoxicillinNitrofurantoin ClarithromycinOxytetracycline DoxycyclinePenicillin V Flucloxacillin Trimethoprim Metronidazole(Erythromycin) Aim for 85% of prescribing to be these Linezolid = HOSPITAL PRESCRIBING ONLY

C Diff THINK – Patient - aged 65+, frequent Abx, recent Abx – Environment – contact, hospital admission, institutionalised – Action – avoid high risk: cephalosporins, ciprofloxacin/quinolones, clindamycin, co- amoxiclav TEST TREAT

Role of 4C antibiotics on local guidelines Sinusitis – 1 st = amoxicillin, 2 nd = doxycycline – Co-amoxiclav 625mg tds x21 for persistant symptoms only COPD exacerbation – 1 st – amoxicilllin, 2 nd = doxycycline – Co-amoxiclav 625mg tds x15 if resistant risk factors Prostatitis  Ciprofloxacin 500mg BD x56 Cellulitis/Wounds – 1 st = flucloxacillin, 2 nd = clarithromycin – Co-amoxiclav 625mg tds x21 only if facial involvement Human/Animal Bites  Co-amoxiclav 625mg tds x21 Pyelonephritis  Co-amoxiclav 625mg tds x42  Ciprofloxacin 500mg bd x14

Minocycline No clear evidence better than alternatives Safety concerns + monitoring Higher cost: Minocycline 100mg M/R caps OD£10.04Doxycycline 100mg caps OD£3.92 Minocycline 100mg caps OD£13.09Lymecycline 408mg caps OD£6.22 Minocycline 100mg tabs OD£13.72Erythromycin 250mg tabs 2BD£7.96 Minocycline 50mg caps BD£15.27Oxytetracycline 250mg tabs 2BD£5.32 Minocycline 50mg tabs BD£ day courses (Drug Tariff August 2013)

Diabetic Drugs Prescribe all insulin by brand name Blood Glucose Testing advice – Type 1 - appropriate amounts – Type 2 - see local guidance – Consider latest DVLA advice also – local guidance under review as a result Insulin Passports – NPSA safety alert, all patients aged 18+ using insulin should have or have opted out

Bisphosphonates Alendronate or Risedronate 1 st line Strontium has VTE warning – Avoid if current/previous VTE – Avoid if temporary/permanent immobilisation

Prescribing Engagement Scheme MANDATORY - Review of repeat prescribing and dispensing systems AND engagement with Pharmicus / Medicines Optimisation support FINANCIAL – Collectively deliver financial balance for CCG ALL 3 AREASEmollient s – Gateshead Wound management1 st line antidepressants - Gateshead Strong opioid prescribing (morphine) Erectile Dysfunction Drugs – Newcastle Ezetimibe – Newcastle North & East LaxativesEffervescent analgesics – Newcastle West Venlafaxine MR caps to MR tabs – Newcastle West Specials – Newcastle North & East

Useful websites Gateshead Information Network North of Tyne Area Prescribing Committe Electronic Medicines Compendium Athens registration Medicines and Prescribing support from NICE